| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.7B | $9.2B | $9.0B | $9.2B | $7.1B | $9.9B | $9.7B | $8.9B |
| Cost of Revenue | $3.5B | $3.9B | $3.9B | $3.8B | $3.4B | $4.5B | $4.3B | — |
| Gross Profit | $5.1B | $5.4B | $5.1B | $5.3B | $3.8B | $5.4B | $5.3B | $4.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.4B | $4.5B | $4.4B | $4.5B | $4.0B | $4.7B | $4.4B | $4.2B |
| Operating Income | $0.8B | $0.9B | $0.5B | $1.1B | $-1.1B | $0.6B | $0.9B | $0.6B |
| Net Income | $0.6B | $0.7B | $0.2B | $1.0B | $-1.1B | $0.4B | $0.7B | $0.5B |
| EPS (Basic) | $10.69 | $10.88 | $3.05 | $13.45 | $-15.96 | $5.63 | $9.75 | $6.93 |
| EPS (Diluted) | $10.56 | $10.76 | $3.03 | $13.25 | $-15.96 | $5.60 | $9.65 | $6.84 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.0B | $11.2B | $11.8B | $12.4B | $13.3B | $13.6B | $11.9B | $11.9B |
| Current Assets | $3.5B | $3.3B | $3.6B | $3.7B | $3.9B | $3.4B | $3.2B | $3.0B |
| Cash & Equivalents | $0.7B | $0.7B | $0.6B | $1.2B | $1.7B | $0.5B | $0.5B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.7B | $2.8B | $2.8B | $2.8B | $2.6B | $2.4B | $1.9B | $1.9B |
| Stockholders' Equity | $5.1B | $5.1B | $5.0B | $5.3B | $4.7B | $5.8B | $5.8B | $5.5B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $1.0B | $0.0B | $1.1B | $0.7B | $1.0B | $0.9B | $0.7B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.3B | $-0.0B | $-0.1B | $-0.5B | $-0.4B | $-0.5B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.3B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.6B | $-0.7B | $-0.4B | $-1.4B | $0.5B | $-0.5B | $-0.5B | $-0.5B |